Endonovo Therapeutics, Inc. (ENDV)
USD 0.0
(14.29%)
USD 0.0
(14.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 121.87 Thousand | -678.83 Thousand | -986.58 Thousand | -741.59 Thousand | -2.54 Million | -2.87 Million |
| Net Income | 6.92 Million | -18.47 Million | -3.1 Million | -395.58 Thousand | -17.31 Million | -6.43 Million |
| Depreciation & Amortization | 646.91 Thousand | 646.91 Thousand | 648.49 Thousand | 651.24 Thousand | 650.31 Thousand | 650.21 Thousand |
| Deferred income taxes | -2.45 Million | - | -95.25 Thousand | -5.05 Million | -194.65 Thousand | - |
| Stock-based compensation | 686.74 Thousand | 45 Thousand | 95.25 Thousand | 456.51 Thousand | 194.65 Thousand | 627.7 Thousand |
| Change in working capital | 1.7 Million | 2 Million | 1.22 Million | 1.88 Million | 1.61 Million | 878.94 Thousand |
| Other non-cash items | -9.84 Million | 15.09 Million | 247.19 Thousand | 1.7 Million | 12.5 Million | 2.02 Million |
| Investing Cash Flow | - | - | - | - | -2594.00 | -8969.00 |
| Investments in PPE | - | - | - | - | -2594.00 | -8969.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -2594.00 | -8969.00 |
| Financing Cash Flow | -120.13 Thousand | 593 Thousand | 1.05 Million | 736.11 Thousand | 2.18 Million | 3.17 Million |
| Debt repayment | -130.85 Thousand | -451 Thousand | -933.1 Thousand | -608.11 Thousand | -130 Thousand | -559.72 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10.72 Thousand | 142 Thousand | 126 Thousand | 150 Thousand | 423.34 Thousand | 787.5 Thousand |
| Other Financing Activities | -9800.00 | 902 Thousand | -16.9 Thousand | 128 Thousand | 1.89 Million | 2.94 Million |
| Accounts receivables | - | - | -2.00 | 21.8 Thousand | -19.39 Thousand | -3345.00 |
| Accounts payables | -478.5 Thousand | 269.39 Thousand | -42.47 Thousand | 94.2 Thousand | 442.08 Thousand | 63.23 Thousand |
| Inventory | - | - | 757.84 Thousand | 819.39 Thousand | 1 Million | 644.88 Thousand |
| Other working capital | 2.18 Million | 1.73 Million | 507.24 Thousand | 952.74 Thousand | 185.61 Thousand | 174.17 Thousand |
| Cash at beginning of period | 98.00 | 85.93 Thousand | 13.42 Thousand | 18.89 Thousand | 379.15 Thousand | 90.17 Thousand |
| Cash at end of period | 1838.00 | 98.00 | 85.93 Thousand | 13.42 Thousand | 18.89 Thousand | 379.15 Thousand |
| Capital Expenditure | - | - | - | - | -2594.00 | -8969.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1740.00 | -85.83 Thousand | 72.51 Thousand | -5473.00 | -360.25 Thousand | 288.97 Thousand |
| Free Cash Flow | 121.87 Thousand | -678.83 Thousand | -986.58 Thousand | -741.59 Thousand | -2.54 Million | -2.88 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -721.29 Thousand | -709.37 Thousand | 6.92 Million | -1.6 Million | -766.17 Thousand | 2.06 Million |
| Depreciation & Amortization | 161.72 Thousand | 161.72 Thousand | 646.91 Thousand | 161.72 Thousand | 161.72 Thousand | 161.72 Thousand |
| Deferred income taxes | - | - | -2.45 Million | -1.33 Million | - | -620.84 Thousand |
| Stock-based compensation | - | - | 686.74 Thousand | 485.78 Thousand | -365.53 Thousand | 620.84 Thousand |
| Change in working capital | 560.6 Thousand | 545.44 Thousand | 1.7 Million | 457.85 Thousand | 294.14 Thousand | 500.32 Thousand |
| Other non-cash items | 294.25 Thousand | 306.45 Thousand | -9.84 Million | 1.02 Million | 610.46 Thousand | -2.89 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 1.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -465.00 | 573.00 | -120.13 Thousand | -524.39 Thousand | 32.76 Thousand | 187.5 Thousand |
| Debt repayment | -42.17 Thousand | -14.42 Thousand | -130.85 Thousand | -278.35 Thousand | -20 Thousand | -4500.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 41.7 Thousand | 15 Thousand | 10.72 Thousand | -246.04 Thousand | 3765.00 | 46 Thousand |
| Other Financing Activities | - | - | -9800.00 | - | 49 Thousand | 146 Thousand |
| Accounts receivables | - | - | - | - | - | 3120.00 |
| Accounts payables | 29.2 Thousand | 17 Thousand | -478.5 Thousand | -528.03 Thousand | -25.29 Thousand | 34.81 Thousand |
| Inventory | - | - | - | - | - | -3120.00 |
| Other working capital | 531.4 Thousand | 528.44 Thousand | 2.18 Million | 985.89 Thousand | 319.43 Thousand | 465.51 Thousand |
| Cash at beginning of period | 206.00 | 1838.00 | 98.00 | - | 32.6 Thousand | 10.94 Thousand |
| Cash at end of period | 780.00 | 206.00 | 1838.00 | 1838.00 | -766.17 Thousand | 32.6 Thousand |
| Capital Expenditure | 1.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 574.00 | -1632.00 | 1740.00 | 1838.00 | -798.77 Thousand | 21.66 Thousand |
| Free Cash Flow | 1040.00 | -2205.00 | 121.87 Thousand | 526.23 Thousand | -65.36 Thousand | -165.84 Thousand |
CHN
BDCM
FBGI
MULTI
SVKEF
603466